Cayman Chemical Eicosanoid Affinity Column Bu
A GPBAR1 antagonist inhibits taurolithocholic acid-induced increases in cAMP levels in and proliferation of cholangiocytes isolated from patients with autosomal dominant polycystic kidney disease at 100 and 200 UM decreases the viability of and protein levels of GPBAR1 in PANC-1 cells at 10 UM prevents B. pseudocatenulatum-induced decreases in serum levels of IFN-Y and IL-17A in a mouse model of collagen-induced arthritis at 80 mg/kg